LITTLE FALLS, N.J.,
Nov. 26, 2013 /PRNewswire/ --
CANTEL MEDICAL CORP. (NYSE:CMN) will release the results for
its first quarter ended October 31,
2013 on Thursday, December 5
before the market opens, and hold a conference call to discuss the
results at 11:00 AM ET. Participating
in the call will be Charles M.
Diker, Chairman; Andrew A.
Krakauer, President and CEO; Jorgen
B. Hansen, Executive Vice President and COO; Craig A. Sheldon, Senior Vice President, CFO and
Treasurer; and Seth Yellin, Senior
Vice President-Corporate Development.
To participate in the conference call, dial (877) 407-8033
approximately 5 to 10 minutes before the beginning of the call. If
you are unable to participate, a digital replay of the call will be
available from Thursday, December 5,
2013 through midnight on February 5,
2014 by dialing (877) 660-6853 and using conference ID #
13573107.
The call will be simultaneously broadcast live over the Internet
on vcall.com at
http://www.investorcalendar.com/IC/CEPage.asp?ID=171967. A replay
of the webcast will be available for 90 days on PrecisionIR and via
the investor relations page of the Cantel web site.
About Cantel Medical Corp.
Cantel Medical is a leading global company dedicated to
delivering innovative infection prevention and control products and
services for patients, caregivers, and other healthcare providers
which improve outcomes, enhance safety and help save lives. Our
products include specialized medical device reprocessing systems
for endoscopy and renal dialysis, advanced water purification
equipment, sterilants, disinfectants and cleaners, sterility
assurance monitoring products for hospitals and dental clinics,
disposable infection control products primarily for dental and GI
endoscopy markets, dialysate concentrates, hollow fiber membrane
filtration and separation products, and specialty packaging for
infectious and biological specimens. Additionally, we provide
technical service for our products. For further information, visit
the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.